Solid Biosciences Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Solid Biosciences Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
SLDB
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001707502

Board of directors

Follow this board

Chief executives

Alexander Cumbo · President and CEO
Dates unknown

Board connections

11 of this board's directors also sit on 37 other boards.

Network of Solid Biosciences Inc.'s board connections Freenome Inc. Freenome Inc. Climb Bio Inc. Climb Bio Inc. Stoke Therapeutics Inc. Stoke Therapeutics Inc... Vor Biopharma Inc. Vor Biopharma Inc. ARS Pharmaceuticals Inc. ARS Pharmaceuticals In... Acrivon Therapeutics Inc. Acrivon Therapeutics I... Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals... Artiva Biotherapeutics Inc. Artiva Biotherapeutics... Bicara Therapeutics Inc. Bicara Therapeutics In... Black Diamond Therapeutics Inc. Black Diamond Therapeu... Evommune Inc. Evommune Inc. Foghorn Therapeutics Inc. Foghorn Therapeutics I... Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... Immatics N.V. Immatics N.V. Jade Biosciences Inc. Jade Biosciences Inc. Janux Therapeutics Inc. Janux Therapeutics Inc... Adam Koppel Adam Koppel Adam Leo Stone Adam Leo Stone Alexander Cumbo Alexander Cumbo Clare Kahn Clare Kahn Ian F. Smith Ian F. Smith Joseph Edelman Joseph Edelman Peter Kolchinsky Peter Kolchinsky Rajeev M. Shah Rajeev M. Shah Solid Biosciences Inc.
Shared director Other board Same sector +21 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$2,681,927
29 sales by 7 insiders
Date Insider Transaction Shares Price Value
Jul 2, 2026 Ian F. Smith Director Option exercise +3,440 — —
Apr 2, 2026 Ian F. Smith Director Option exercise +3,441 — —
Feb 18, 2026 Alexander Cumbo Director, Officer (President and CEO) Open-market sale −16,644 $5.82 $96,868
Feb 18, 2026 Hanrahan Jessie Officer (Chief Regulatory Officer) Open-market sale −4,134 $5.82 $24,060
Feb 18, 2026 Ilan Ganot Director Open-market sale −2,658 $5.82 $15,470
Feb 18, 2026 Herzich Paul Officer (Chief Technology Officer) Open-market sale −3,616 $5.82 $21,045
Feb 18, 2026 Howton David T Officer (Chief Operating Officer) Open-market sale −7,469 $5.82 $43,470
Feb 18, 2026 Brooks Gabriel Officer (Chief Medical Officer) Open-market sale −0 $5.82 $0
Feb 18, 2026 Tan Kevin Officer (CFO & Treasurer) Open-market sale −5,404 $5.82 $31,451
Feb 13, 2026 Alexander Cumbo Director, Officer (President and CEO) Option exercise +30,031 — —
Feb 13, 2026 Hanrahan Jessie Officer (Chief Regulatory Officer) Option exercise +8,125 — —
Feb 13, 2026 Ilan Ganot Director Option exercise +4,861 — —
Feb 13, 2026 Herzich Paul Officer (Chief Technology Officer) Option exercise +7,187 — —
Feb 13, 2026 Howton David T Officer (Chief Operating Officer) Option exercise +14,687 — —
Feb 13, 2026 Brooks Gabriel Officer (Chief Medical Officer) Option exercise +10,937 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.